Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2008 ◽  
Vol 61 (1) ◽  
pp. 82-90 ◽  
Author(s):  
F. Anthony Greco ◽  
Philip Bonomi ◽  
Jeffrey Crawford ◽  
Karen Kelly ◽  
Yun Oh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Monoclonal Antibody ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Trail Receptor ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Study

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2012 ◽  
Vol 76 (1) ◽  
pp. 78-83 ◽  
Author(s):  
Benjamin Besse ◽  
David Planchard ◽  
Anne-Sophie Veillard ◽  
Laurent Taillade ◽  
David Khayat ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Study
Sign in / Sign up

Export Citation Format

Share Document